O	O	0	10	Activation	Activation	B-NP	NN	O	0	ROOT	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
O	O	14	27	transcription	transcription	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	28	34	factor	factor	I-NP	NN	I-protein	8	NMOD	I-protein
T5	B-Entity	35	37	NF	NF	I-NP	NN	B-protein	8	NMOD	B-protein
T5	I-Entity	37	38	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T5	I-Entity	38	43	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T5	I-Entity	44	45	B	B	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	46	48	by	by	B-PP	IN	O	1	NMOD	O
O	O	49	59	phagocytic	phagocytic	B-NP	JJ	O	11	NMOD	O
O	O	60	67	stimuli	stimulus	I-NP	NNS	O	9	PMOD	O
O	O	68	70	in	in	B-PP	IN	O	1	NMOD	O
O	O	71	76	human	human	B-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	77	88	neutrophils	neutrophil	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	88	89	.	.	O	.	O	1	P	O

O	O	91	103	Phagocytosis	Phagocytosis	B-NP	NN	O	2	SUB	O
O	O	104	114	represents	represent	B-VP	VBZ	O	0	ROOT	O
O	O	115	117	an	an	B-NP	DT	O	6	NMOD	O
O	O	118	127	important	important	I-NP	JJ	O	5	AMOD	O
O	O	128	141	physiological	physiological	I-NP	JJ	O	6	NMOD	O
O	O	142	149	trigger	trigger	I-NP	NN	O	2	OBJ	O
O	O	150	153	for	for	B-PP	IN	O	6	NMOD	O
O	O	154	157	the	the	B-NP	DT	O	10	NMOD	O
O	O	158	167	inducible	inducible	I-NP	JJ	O	10	NMOD	O
O	O	168	178	expression	expression	I-NP	NN	O	7	PMOD	O
O	O	179	181	of	of	B-PP	IN	O	10	NMOD	O
T6	B-Entity	182	189	several	several	B-NP	JJ	O	13	NMOD	O
T6	I-Entity	190	195	genes	gene	I-NP	NNS	O	11	PMOD	O
O	O	196	198	in	in	B-PP	IN	O	10	NMOD	O
O	O	199	204	human	human	B-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	205	216	neutrophils	neutrophil	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	216	217	.	.	O	.	O	2	P	O

O	O	218	222	Here	Here	B-ADVP	RB	O	4	VMOD	O
O	O	222	223	,	,	O	,	O	4	P	O
O	O	224	226	we	we	B-NP	PRP	O	4	SUB	O
O	O	227	233	report	report	B-VP	VBP	O	0	ROOT	O
O	O	234	238	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	239	240	a	a	B-NP	DT	O	7	NMOD	O
T7	B-Entity	241	244	DNA	DNA	I-NP	NN	O	10	NMOD	O
O	O	244	245	-	-	O	HYPH	O	7	P	O
O	O	245	252	binding	bind	B-NP	VBG	O	10	NMOD	O
O	O	253	261	activity	activity	I-NP	NN	O	26	SUB	O
O	O	262	271	primarily	primarily	B-VP	RB	O	12	VMOD	O
O	O	272	282	consisting	consist	I-VP	VBG	O	10	NMOD	O
O	O	283	285	of	of	B-PP	IN	O	12	VMOD	O
O	O	286	289	the	the	B-NP	DT	O	20	NMOD	O
O	O	290	299	classical	classical	I-NP	JJ	O	20	NMOD	O
T8	B-Entity	300	302	NF	NF	I-NP	NN	B-protein	20	NMOD	B-protein
T8	I-Entity	302	303	-	-	B-NP	HYPH	I-protein	20	NMOD	I-protein
T8	I-Entity	303	308	kappa	kappa	I-NP	NN	I-protein	20	NMOD	I-protein
T8	I-Entity	309	310	B	B	I-NP	NN	I-protein	20	NMOD	I-protein
T8	I-Entity	311	322	heterodimer	heterodimer	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	322	323	,	,	O	,	O	24	P	O
T1,T9	B-Protein,B-Entity	324	327	p50	p50	B-NP	NN	B-protein	24	NMOD	B-protein
T9	I-Entity	327	328	/	/	B-NP	SYM	O	24	NMOD	O
T2,T9	B-Protein,I-Entity	328	332	RelA	RelA	I-NP	NN	B-protein	13	PMOD	B-protein
O	O	332	333	,	,	O	,	O	10	P	O
O	O	334	336	is	be	B-VP	VBZ	O	5	SBAR	O
O	O	337	344	induced	induce	I-VP	VBN	O	26	VC	O
O	O	345	347	in	in	B-PP	IN	O	27	VMOD	O
O	O	348	361	phagocytosing	phagocytose	B-VP	VBG	B-cell_type	30	NMOD	B-cell_type
O	O	362	373	neutrophils	neutrophil	B-NP	NNS	I-cell_type	28	PMOD	I-cell_type
O	O	373	374	.	.	O	.	O	4	P	O

O	O	375	380	Under	Under	B-PP	IN	O	10	VMOD	O
O	O	381	386	these	these	B-NP	DT	O	3	NMOD	O
O	O	387	397	conditions	condition	I-NP	NNS	O	1	PMOD	O
O	O	397	398	,	,	O	,	O	10	P	O
T10	B-Entity	399	401	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T10	I-Entity	401	402	-	-	I-NP	HYPH	I-protein	9	NMOD	I-protein
T10	I-Entity	402	407	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T10	I-Entity	408	409	B	B	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	410	420	activation	activation	I-NP	NN	O	10	SUB	O
O	O	421	424	was	be	B-VP	VBD	O	0	ROOT	O
O	O	425	430	found	find	I-VP	VBN	O	10	VC	O
O	O	431	433	to	to	I-VP	TO	O	13	VMOD	O
O	O	434	436	be	be	I-VP	VB	O	11	VMOD	O
O	O	437	438	a	a	B-NP	DT	O	18	NMOD	O
O	O	439	444	rapid	rapid	I-NP	JJ	O	17	AMOD	O
O	O	445	448	and	and	I-NP	CC	O	17	AMOD	O
O	O	449	458	transient	transient	I-NP	JJ	O	18	NMOD	O
O	O	459	467	response	response	I-NP	NN	O	13	PRD	O
O	O	467	468	,	,	O	,	O	18	P	O
O	O	469	477	reaching	reach	B-VP	VBG	O	18	NMOD	O
O	O	478	479	a	a	B-NP	DT	O	22	NMOD	O
O	O	480	487	maximum	maximum	I-NP	NN	O	20	OBJ	O
O	O	488	490	by	by	B-PP	IN	O	20	VMOD	O
O	O	491	493	10	10	B-NP	CD	O	27	NMOD	O
O	O	493	494	-	-	I-NP	HYPH	O	27	NMOD	O
O	O	494	496	15	15	I-NP	CD	O	27	NMOD	O
O	O	497	500	min	min	I-NP	NN	O	23	PMOD	O
O	O	500	501	,	,	O	,	O	20	P	O
O	O	502	505	and	and	O	CC	O	20	VMOD	O
O	O	506	515	returning	return	B-VP	VBG	O	20	VMOD	O
O	O	516	518	to	to	B-PP	TO	O	30	VMOD	O
O	O	519	523	near	near	B-NP	JJ	O	35	NMOD	O
O	O	523	524	-	-	I-NP	HYPH	O	35	NMOD	O
O	O	524	529	basal	basal	I-NP	JJ	O	35	NMOD	O
O	O	530	536	levels	level	I-NP	NNS	O	31	PMOD	O
O	O	537	539	by	by	B-PP	IN	O	30	VMOD	O
O	O	540	542	30	30	B-NP	CD	O	38	NMOD	O
O	O	543	546	min	min	I-NP	NN	O	36	PMOD	O
O	O	546	547	.	.	O	.	O	10	P	O

O	O	548	550	In	In	B-PP	IN	O	42	VMOD	O
O	O	551	562	neutrophils	neutrophil	B-NP	NNS	B-cell_type	1	PMOD	B-cell_type
O	O	563	573	undergoing	undergo	B-VP	VBG	O	2	NMOD	O
O	O	574	577	the	the	B-NP	DT	O	5	NMOD	O
O	O	578	590	phagocytosis	phagocytosis	I-NP	NN	O	3	OBJ	O
O	O	591	593	of	of	B-PP	IN	O	5	NMOD	O
O	O	594	603	opsonized	opsonize	B-NP	VBN	O	8	NMOD	O
O	O	604	610	yeasts	yeast	I-NP	NNS	O	6	PMOD	O
O	O	610	611	,	,	O	,	O	42	P	O
O	O	612	615	the	the	B-NP	DT	O	11	NMOD	O
O	O	616	621	onset	onset	I-NP	NN	O	18	SUB	O
O	O	622	624	of	of	B-PP	IN	O	11	NMOD	O
T11	B-Entity	625	627	NF	NF	B-NP	NN	B-protein	17	NMOD	B-protein
T11	I-Entity	627	628	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
T11	I-Entity	628	633	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
T11	I-Entity	634	635	B	B	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	636	646	activation	activation	I-NP	NN	O	12	PMOD	O
O	O	647	650	was	be	B-VP	VBD	O	42	VMOD	O
O	O	651	661	paralleled	parallel	I-VP	VBN	O	18	VC	O
O	O	662	664	by	by	B-PP	IN	O	19	VMOD	O
O	O	665	666	a	a	B-NP	DT	O	22	NMOD	O
O	O	667	674	decline	decline	I-NP	NN	O	20	PMOD	O
O	O	675	677	in	in	B-PP	IN	O	22	NMOD	O
O	O	678	692	immunoreactive	immunoreactive	B-NP	JJ	O	31	NMOD	O
T3	B-Protein	693	694	I	I	I-NP	NN	B-protein	27	NMOD	B-protein
T3	I-Protein	695	700	kappa	kappa	I-NP	NN	I-protein	27	NMOD	I-protein
T3	I-Protein	701	702	B	B	I-NP	NN	I-protein	24	NMOD	I-protein
T3	I-Protein	702	703	-	-	O	HYPH	O	31	NMOD	O
T3	I-Protein	703	708	alpha	alpha	B-NP	SYM	O	31	NMOD	O
O	O	709	716	protein	protein	I-NP	NN	O	31	NMOD	O
O	O	717	723	levels	level	I-NP	NNS	O	23	PMOD	O
O	O	723	724	,	,	O	,	O	42	P	O
O	O	725	728	and	and	O	CC	O	42	VMOD	O
O	O	729	732	the	the	B-NP	DT	O	38	NMOD	O
O	O	733	741	cellular	cellular	I-NP	JJ	O	38	NMOD	O
T4	B-Protein	742	743	I	I	I-NP	NN	B-protein	38	NMOD	B-protein
T4	I-Protein	744	749	kappa	kappa	I-NP	NN	I-protein	38	NMOD	I-protein
T4	I-Protein	750	751	B	B	I-NP	NN	I-protein	41	NMOD	I-protein
T4	I-Protein	751	752	-	-	O	HYPH	O	41	NMOD	O
T4	I-Protein	752	757	alpha	alpha	B-NP	SYM	O	41	NMOD	O
O	O	758	762	pool	pool	I-NP	NN	O	42	SUB	O
O	O	763	766	was	be	B-VP	VBD	O	0	ROOT	O
O	O	767	778	replenished	replenish	I-VP	VBN	O	42	VC	O
O	O	779	781	by	by	B-PP	IN	O	43	VMOD	O
O	O	782	784	30	30	B-NP	CD	O	46	NMOD	O
O	O	785	788	min	min	I-NP	NN	O	44	PMOD	O
O	O	788	789	,	,	O	,	O	43	P	O
O	O	790	792	in	in	B-PP	IN	O	43	VMOD	O
O	O	793	802	agreement	agreement	B-NP	NN	O	48	PMOD	O
O	O	803	807	with	with	B-PP	IN	O	49	NMOD	O
O	O	808	811	our	our	B-NP	PRP$	O	54	NMOD	O
O	O	812	815	gel	gel	I-NP	NN	O	54	NMOD	O
O	O	816	821	shift	shift	I-NP	NN	O	54	NMOD	O
O	O	822	826	data	datum	I-NP	NNS	O	50	PMOD	O
O	O	826	827	.	.	O	.	O	42	P	O

O	O	828	830	We	We	B-NP	PRP	O	2	SUB	O
O	O	831	839	conclude	conclude	B-VP	VBP	O	0	ROOT	O
O	O	840	844	that	that	B-SBAR	IN	O	2	VMOD	O
T12	B-Entity	845	847	NF	NF	B-NP	NN	B-protein	8	NMOD	B-protein
T12	I-Entity	847	848	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T12	I-Entity	848	853	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T12	I-Entity	854	855	B	B	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	856	866	activation	activation	I-NP	NN	O	9	SUB	O
O	O	867	872	could	could	B-VP	MD	O	3	SBAR	O
O	O	873	883	constitute	constitute	I-VP	VB	O	9	VC	O
O	O	884	887	one	one	B-NP	CD	O	10	OBJ	O
O	O	888	890	of	of	B-PP	IN	O	11	NMOD	O
O	O	891	894	the	the	B-NP	DT	O	14	NMOD	O
O	O	895	905	mechanisms	mechanism	I-NP	NNS	O	12	PMOD	O
O	O	906	913	whereby	whereby	B-ADVP	WRB	O	11	NMOD	O
O	O	914	917	the	the	B-NP	DT	O	17	NMOD	O
O	O	918	928	expression	expression	I-NP	NN	O	24	SUB	O
O	O	929	931	of	of	B-PP	IN	O	17	NMOD	O
T13	B-Entity	932	937	kappa	kappa	B-NP	NN	B-DNA	23	NMOD	B-DNA
T13	I-Entity	938	939	B	B	I-NP	NN	I-DNA	23	NMOD	I-DNA
T13	I-Entity	939	940	-	-	B-NP	HYPH	I-DNA	23	NMOD	I-DNA
T13	I-Entity	940	950	responsive	responsive	I-NP	JJ	I-DNA	23	NMOD	I-DNA
T13	I-Entity	951	956	genes	gene	I-NP	NNS	I-DNA	18	PMOD	I-DNA
O	O	957	959	is	be	B-VP	VBZ	O	15	SBAR	O
O	O	960	968	enhanced	enhance	I-VP	VBN	O	24	VC	O
O	O	969	971	in	in	B-PP	IN	O	25	VMOD	O
O	O	972	985	phagocytosing	phagocytose	B-VP	VBG	B-cell_type	28	NMOD	B-cell_type
O	O	986	997	neutrophils	neutrophil	B-NP	NNS	I-cell_type	26	PMOD	I-cell_type
O	O	997	998	.	.	O	.	O	2	P	O

O	O	999	1001	To	To	B-PP	TO	O	6	VMOD	O
O	O	1002	1005	our	our	B-NP	PRP$	O	3	NMOD	O
O	O	1006	1015	knowledge	knowledge	I-NP	NN	O	1	PMOD	O
O	O	1015	1016	,	,	O	,	O	6	P	O
O	O	1017	1021	this	this	B-NP	DT	O	6	SUB	O
O	O	1022	1032	represents	represent	B-VP	VBZ	O	0	ROOT	O
O	O	1033	1036	the	the	B-NP	DT	O	9	NMOD	O
O	O	1037	1042	first	first	I-NP	JJ	O	9	NMOD	O
O	O	1043	1056	demonstration	demonstration	I-NP	NN	O	6	OBJ	O
O	O	1057	1061	that	that	B-NP	IN	O	9	NMOD	O
O	O	1062	1072	phagocytic	phagocytic	B-NP	JJ	O	12	NMOD	O
O	O	1073	1080	stimuli	stimulus	I-NP	NNS	O	13	SUB	O
O	O	1081	1084	can	can	B-VP	MD	O	10	SBAR	O
O	O	1085	1091	induce	induce	I-VP	VB	O	13	VC	O
T14	B-Entity	1092	1094	NF	NF	B-NP	NN	B-protein	19	NMOD	B-protein
T14	I-Entity	1094	1095	-	-	B-NP	HYPH	I-protein	19	NMOD	I-protein
T14	I-Entity	1095	1100	kappa	kappa	I-NP	NN	I-protein	19	NMOD	I-protein
T14	I-Entity	1101	1102	B	B	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	1103	1113	activation	activation	I-NP	NN	O	14	OBJ	O
O	O	1114	1116	in	in	B-PP	IN	O	14	VMOD	O
O	O	1117	1122	human	human	B-NP	JJ	B-cell_type	22	NMOD	B-cell_type
O	O	1123	1134	neutrophils	neutrophil	I-NP	NNS	I-cell_type	20	PMOD	I-cell_type
O	O	1134	1135	.	.	O	.	O	6	P	O
